
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8963002
[patent_doc_number] => 20130202604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'Therapeutic Uses of Monoclonal Antibodies to the Angiotensin-II Type-1 Receptor'
[patent_app_type] => utility
[patent_app_number] => 13/749180
[patent_app_country] => US
[patent_app_date] => 2013-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5870
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13749180
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/749180 | Therapeutic Uses of Monoclonal Antibodies to the Angiotensin-II Type-1 Receptor | Jan 23, 2013 | Abandoned |
Array
(
[id] => 8916359
[patent_doc_number] => 20130177984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'Tumor Suppressor Gene, p28ING5'
[patent_app_type] => utility
[patent_app_number] => 13/747282
[patent_app_country] => US
[patent_app_date] => 2013-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 30173
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13747282
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/747282 | Tumor Suppressor Gene, p28ING5 | Jan 21, 2013 | Abandoned |
Array
(
[id] => 10176271
[patent_doc_number] => 09206467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Tyrosine kinome'
[patent_app_type] => utility
[patent_app_number] => 13/746376
[patent_app_country] => US
[patent_app_date] => 2013-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 4919
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13746376
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/746376 | Tyrosine kinome | Jan 21, 2013 | Issued |
Array
(
[id] => 16695535
[patent_doc_number] => 10946104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Aberrant cell-restricted immunoglobulins provided with a toxic moiety
[patent_app_type] => utility
[patent_app_number] => 14/372094
[patent_app_country] => US
[patent_app_date] => 2013-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 12127
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14372094
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/372094 | Aberrant cell-restricted immunoglobulins provided with a toxic moiety | Jan 10, 2013 | Issued |
Array
(
[id] => 10498561
[patent_doc_number] => 09226951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Anti-tumor fibrillar human serum albumin methods and compositions'
[patent_app_type] => utility
[patent_app_number] => 13/738856
[patent_app_country] => US
[patent_app_date] => 2013-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 7743
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13738856
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/738856 | Anti-tumor fibrillar human serum albumin methods and compositions | Jan 9, 2013 | Issued |
Array
(
[id] => 9295520
[patent_doc_number] => 20140039154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'PROTEIN DISULFIDE ISOMERASE ASSAY METHOD FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/732521
[patent_app_country] => US
[patent_app_date] => 2013-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26977
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13732521
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/732521 | Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer | Jan 1, 2013 | Issued |
Array
(
[id] => 10911742
[patent_doc_number] => 20140314758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'IMMUNOGENIC TUMOR ASSOCIATED STROMAL CELL ANTIGEN PEPTIDES AND METHODS OF THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 14/358705
[patent_app_country] => US
[patent_app_date] => 2012-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 45660
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358705
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/358705 | Immunogenic tumor associated stromal cell antigen peptides and methods of their use | Nov 14, 2012 | Issued |
Array
(
[id] => 10627643
[patent_doc_number] => 09345782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Therapeutic agents and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/354617
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 29
[patent_no_of_words] => 19053
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354617
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354617 | Therapeutic agents and uses thereof | Oct 25, 2012 | Issued |
Array
(
[id] => 10905287
[patent_doc_number] => 20140308301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'CD44 MONOCLONAL ANTIBODY FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER HEMATOLOGICAL MALIGNANCIES'
[patent_app_type] => utility
[patent_app_number] => 14/354472
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19222
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354472
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354472 | CD44 MONOCLONAL ANTIBODY FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER HEMATOLOGICAL MALIGNANCIES | Oct 25, 2012 | Abandoned |
Array
(
[id] => 8865602
[patent_doc_number] => 20130149305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'SOLUBLE CD80 AS A THERAPEUTIC TO REVERSE IMMUNE SUPRESSION IN CANCER PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/660037
[patent_app_country] => US
[patent_app_date] => 2012-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11729
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13660037
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/660037 | Soluble CD80 as a therapeutic to reverse immune supression in cancer patients | Oct 24, 2012 | Issued |
Array
(
[id] => 9306097
[patent_doc_number] => 20140044771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'ENZYME PRODRUG CANCER THERAPY SELECTIVELY TARGETED TO TUMOR VASCULATURE AND METHODS OF PRODUCTION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/655913
[patent_app_country] => US
[patent_app_date] => 2012-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15557
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655913
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/655913 | Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof | Oct 18, 2012 | Issued |
Array
(
[id] => 8617284
[patent_doc_number] => 20130022596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/630860
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17721
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13630860
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/630860 | METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS | Sep 27, 2012 | Abandoned |
Array
(
[id] => 10225904
[patent_doc_number] => 20150110897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'Sperm Protein as a Detection Biomarker of Early Stage Ovarian Cancer'
[patent_app_type] => utility
[patent_app_number] => 14/345208
[patent_app_country] => US
[patent_app_date] => 2012-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14691
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345208
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/345208 | Sperm Protein as a Detection Biomarker of Early Stage Ovarian Cancer | Sep 11, 2012 | Abandoned |
Array
(
[id] => 10919325
[patent_doc_number] => 20140322344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'VACCINE PREPARATION FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/241321
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7865
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241321
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/241321 | VACCINE PREPARATION FOR CANCER TREATMENT | Aug 29, 2012 | Abandoned |
Array
(
[id] => 8710320
[patent_doc_number] => 20130067608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'COLON CANCER TARGETS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/587215
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 66465
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587215
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/587215 | COLON CANCER TARGETS AND USES THEREOF | Aug 15, 2012 | Abandoned |
Array
(
[id] => 11738303
[patent_doc_number] => 09702879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas'
[patent_app_type] => utility
[patent_app_number] => 14/237682
[patent_app_country] => US
[patent_app_date] => 2012-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 28689
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237682
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237682 | Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas | Aug 7, 2012 | Issued |
Array
(
[id] => 11908265
[patent_doc_number] => 09777068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Method for treating a GD2 positive cancer'
[patent_app_type] => utility
[patent_app_number] => 14/409161
[patent_app_country] => US
[patent_app_date] => 2012-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 22494
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409161
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/409161 | Method for treating a GD2 positive cancer | Jul 30, 2012 | Issued |
Array
(
[id] => 9074568
[patent_doc_number] => 08552146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-08
[patent_title] => 'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 13/562250
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 35
[patent_no_of_words] => 21532
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13562250
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/562250 | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides | Jul 29, 2012 | Issued |
Array
(
[id] => 9656266
[patent_doc_number] => 20140227271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'SOMATIC MUTATIONS IN ATRX IN BRAIN CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/129850
[patent_app_country] => US
[patent_app_date] => 2012-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4693
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129850
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/129850 | Somatic mutations in ATRX in brain cancer | Jun 27, 2012 | Issued |
Array
(
[id] => 9970684
[patent_doc_number] => 09017688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 13/535297
[patent_app_country] => US
[patent_app_date] => 2012-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 35
[patent_no_of_words] => 21538
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13535297
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/535297 | Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides | Jun 26, 2012 | Issued |